Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.
The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.
A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.
The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization''s List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.
In 2019, the market size of Tetanus Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tetanus Vaccine.
This report studies the global market size of Tetanus Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Tetanus Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GlaxoSmithKline plc
Pfizer,Inc
Merck & Co.,Inc
Sanofi Pasteur SA
Biological E
Dano Vaccine &Biological Pvt.Ltd.,
Panera
Shantha Biotechnics Ltd
Market Segment by Product Type
Diphtheria and tetanus (DT) vaccines
Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
Tetanus and diphtheria (Td) vaccines
Tetanus, diphtheria, and pertussis (Tdap) vaccines
Market Segment by Application
Adult
Pediatric
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Tetanus Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Tetanus Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Tetanus Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.
A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.
The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization''s List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.
In 2019, the market size of Tetanus Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tetanus Vaccine.
This report studies the global market size of Tetanus Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Tetanus Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GlaxoSmithKline plc
Pfizer,Inc
Merck & Co.,Inc
Sanofi Pasteur SA
Biological E
Dano Vaccine &Biological Pvt.Ltd.,
Panera
Shantha Biotechnics Ltd
Market Segment by Product Type
Diphtheria and tetanus (DT) vaccines
Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
Tetanus and diphtheria (Td) vaccines
Tetanus, diphtheria, and pertussis (Tdap) vaccines
Market Segment by Application
Adult
Pediatric
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Tetanus Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Tetanus Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Tetanus Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Tetanus Vaccine Market Size Growth Rate by Type (2019-2025)
1.3.2 Diphtheria and tetanus (DT) vaccines
1.3.3 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
1.3.4 Tetanus and diphtheria (Td) vaccines
1.3.5 Tetanus, diphtheria, and pertussis (Tdap) vaccines
1.4 Market Segment by Application
1.4.1 Global Tetanus Vaccine Market Share by Application (2019-2025)
1.4.2 Adult
1.4.3 Pediatric
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tetanus Vaccine Market Size
2.1.1 Global Tetanus Vaccine Revenue 2014-2025
2.1.2 Global Tetanus Vaccine Sales 2014-2025
2.2 Tetanus Vaccine Growth Rate by Regions
2.2.1 Global Tetanus Vaccine Sales by Regions 2014-2019
2.2.2 Global Tetanus Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Tetanus Vaccine Sales by Manufacturers
3.1.1 Tetanus Vaccine Sales by Manufacturers 2014-2019
3.1.2 Tetanus Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Tetanus Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Tetanus Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Tetanus Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Tetanus Vaccine Price by Manufacturers
3.4 Key Manufacturers Tetanus Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Tetanus Vaccine Market
3.6 Key Manufacturers Tetanus Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Diphtheria and tetanus (DT) vaccines Sales and Revenue (2014-2019)
4.1.2 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines Sales and Revenue (2014-2019)
4.1.3 Tetanus and diphtheria (Td) vaccines Sales and Revenue (2014-2019)
4.1.4 Tetanus, diphtheria, and pertussis (Tdap) vaccines Sales and Revenue (2014-2019)
4.2 Global Tetanus Vaccine Sales Market Share by Type
4.3 Global Tetanus Vaccine Revenue Market Share by Type
4.4 Tetanus Vaccine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Tetanus Vaccine Sales by Application
6 United States
6.1 United States Tetanus Vaccine Breakdown Data by Company
6.2 United States Tetanus Vaccine Breakdown Data by Type
6.3 United States Tetanus Vaccine Breakdown Data by Application
7 European Union
7.1 European Union Tetanus Vaccine Breakdown Data by Company
7.2 European Union Tetanus Vaccine Breakdown Data by Type
7.3 European Union Tetanus Vaccine Breakdown Data by Application
8 China
8.1 China Tetanus Vaccine Breakdown Data by Company
8.2 China Tetanus Vaccine Breakdown Data by Type
8.3 China Tetanus Vaccine Breakdown Data by Application
9 Rest of World
9.1 Rest of World Tetanus Vaccine Breakdown Data by Company
9.2 Rest of World Tetanus Vaccine Breakdown Data by Type
9.3 Rest of World Tetanus Vaccine Breakdown Data by Application
9.4 Rest of World Tetanus Vaccine Breakdown Data by Countries
9.4.1 Rest of World Tetanus Vaccine Sales by Countries
9.4.2 Rest of World Tetanus Vaccine Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 GlaxoSmithKline plc
10.1.1 GlaxoSmithKline plc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.1.4 Tetanus Vaccine Product Introduction
10.1.5 GlaxoSmithKline plc Recent Development
10.2 Pfizer,Inc
10.2.1 Pfizer,Inc Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.2.4 Tetanus Vaccine Product Introduction
10.2.5 Pfizer,Inc Recent Development
10.3 Merck & Co.,Inc
10.3.1 Merck & Co.,Inc Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.3.4 Tetanus Vaccine Product Introduction
10.3.5 Merck & Co.,Inc Recent Development
10.4 Sanofi Pasteur SA
10.4.1 Sanofi Pasteur SA Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.4.4 Tetanus Vaccine Product Introduction
10.4.5 Sanofi Pasteur SA Recent Development
10.5 Biological E
10.5.1 Biological E Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.5.4 Tetanus Vaccine Product Introduction
10.5.5 Biological E Recent Development
10.6 Dano Vaccine &Biological Pvt.Ltd.,
10.6.1 Dano Vaccine &Biological Pvt.Ltd., Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.6.4 Tetanus Vaccine Product Introduction
10.6.5 Dano Vaccine &Biological Pvt.Ltd., Recent Development
10.7 Panera
10.7.1 Panera Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.7.4 Tetanus Vaccine Product Introduction
10.7.5 Panera Recent Development
10.8 Shantha Biotechnics Ltd
10.8.1 Shantha Biotechnics Ltd Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.8.4 Tetanus Vaccine Product Introduction
10.8.5 Shantha Biotechnics Ltd Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Tetanus Vaccine Sales Channels
11.2.2 Tetanus Vaccine Distributors
11.3 Tetanus Vaccine Customers
12 Market Forecast
12.1 Global Tetanus Vaccine Sales and Revenue Forecast 2019-2025
12.2 Global Tetanus Vaccine Sales Forecast by Type
12.3 Global Tetanus Vaccine Sales Forecast by Application
12.4 Tetanus Vaccine Forecast by Regions
12.4.1 Global Tetanus Vaccine Sales Forecast by Regions 2019-2025
12.4.2 Global Tetanus Vaccine Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Tetanus Vaccine Market Size Growth Rate by Type (2019-2025)
1.3.2 Diphtheria and tetanus (DT) vaccines
1.3.3 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
1.3.4 Tetanus and diphtheria (Td) vaccines
1.3.5 Tetanus, diphtheria, and pertussis (Tdap) vaccines
1.4 Market Segment by Application
1.4.1 Global Tetanus Vaccine Market Share by Application (2019-2025)
1.4.2 Adult
1.4.3 Pediatric
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tetanus Vaccine Market Size
2.1.1 Global Tetanus Vaccine Revenue 2014-2025
2.1.2 Global Tetanus Vaccine Sales 2014-2025
2.2 Tetanus Vaccine Growth Rate by Regions
2.2.1 Global Tetanus Vaccine Sales by Regions 2014-2019
2.2.2 Global Tetanus Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Tetanus Vaccine Sales by Manufacturers
3.1.1 Tetanus Vaccine Sales by Manufacturers 2014-2019
3.1.2 Tetanus Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Tetanus Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Tetanus Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Tetanus Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Tetanus Vaccine Price by Manufacturers
3.4 Key Manufacturers Tetanus Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Tetanus Vaccine Market
3.6 Key Manufacturers Tetanus Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Diphtheria and tetanus (DT) vaccines Sales and Revenue (2014-2019)
4.1.2 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines Sales and Revenue (2014-2019)
4.1.3 Tetanus and diphtheria (Td) vaccines Sales and Revenue (2014-2019)
4.1.4 Tetanus, diphtheria, and pertussis (Tdap) vaccines Sales and Revenue (2014-2019)
4.2 Global Tetanus Vaccine Sales Market Share by Type
4.3 Global Tetanus Vaccine Revenue Market Share by Type
4.4 Tetanus Vaccine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Tetanus Vaccine Sales by Application
6 United States
6.1 United States Tetanus Vaccine Breakdown Data by Company
6.2 United States Tetanus Vaccine Breakdown Data by Type
6.3 United States Tetanus Vaccine Breakdown Data by Application
7 European Union
7.1 European Union Tetanus Vaccine Breakdown Data by Company
7.2 European Union Tetanus Vaccine Breakdown Data by Type
7.3 European Union Tetanus Vaccine Breakdown Data by Application
8 China
8.1 China Tetanus Vaccine Breakdown Data by Company
8.2 China Tetanus Vaccine Breakdown Data by Type
8.3 China Tetanus Vaccine Breakdown Data by Application
9 Rest of World
9.1 Rest of World Tetanus Vaccine Breakdown Data by Company
9.2 Rest of World Tetanus Vaccine Breakdown Data by Type
9.3 Rest of World Tetanus Vaccine Breakdown Data by Application
9.4 Rest of World Tetanus Vaccine Breakdown Data by Countries
9.4.1 Rest of World Tetanus Vaccine Sales by Countries
9.4.2 Rest of World Tetanus Vaccine Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 GlaxoSmithKline plc
10.1.1 GlaxoSmithKline plc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.1.4 Tetanus Vaccine Product Introduction
10.1.5 GlaxoSmithKline plc Recent Development
10.2 Pfizer,Inc
10.2.1 Pfizer,Inc Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.2.4 Tetanus Vaccine Product Introduction
10.2.5 Pfizer,Inc Recent Development
10.3 Merck & Co.,Inc
10.3.1 Merck & Co.,Inc Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.3.4 Tetanus Vaccine Product Introduction
10.3.5 Merck & Co.,Inc Recent Development
10.4 Sanofi Pasteur SA
10.4.1 Sanofi Pasteur SA Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.4.4 Tetanus Vaccine Product Introduction
10.4.5 Sanofi Pasteur SA Recent Development
10.5 Biological E
10.5.1 Biological E Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.5.4 Tetanus Vaccine Product Introduction
10.5.5 Biological E Recent Development
10.6 Dano Vaccine &Biological Pvt.Ltd.,
10.6.1 Dano Vaccine &Biological Pvt.Ltd., Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.6.4 Tetanus Vaccine Product Introduction
10.6.5 Dano Vaccine &Biological Pvt.Ltd., Recent Development
10.7 Panera
10.7.1 Panera Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.7.4 Tetanus Vaccine Product Introduction
10.7.5 Panera Recent Development
10.8 Shantha Biotechnics Ltd
10.8.1 Shantha Biotechnics Ltd Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Tetanus Vaccine
10.8.4 Tetanus Vaccine Product Introduction
10.8.5 Shantha Biotechnics Ltd Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Tetanus Vaccine Sales Channels
11.2.2 Tetanus Vaccine Distributors
11.3 Tetanus Vaccine Customers
12 Market Forecast
12.1 Global Tetanus Vaccine Sales and Revenue Forecast 2019-2025
12.2 Global Tetanus Vaccine Sales Forecast by Type
12.3 Global Tetanus Vaccine Sales Forecast by Application
12.4 Tetanus Vaccine Forecast by Regions
12.4.1 Global Tetanus Vaccine Sales Forecast by Regions 2019-2025
12.4.2 Global Tetanus Vaccine Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
